Related Experiment Video
Updated: Jul 14, 2026

High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents (HPHC)
Published on: May 10, 2016
The Canadian Natural Health Products (NHP) regulations: industry compliance motivations
Hina Laeeque1, Heather Boon, Natasha Kachan
1Leslie Dan Faculty of Pharmacy, University of Toronto.
Abstract:
This qualitative study explores corporations' motivations to comply with new natural health products (NHP) Regulations in Canada. Interviews were conducted with representatives from 20 Canadian NHP companies. Findings show that the rationale for compliance differs for large compared to small and medium-sized enterprises (SMEs). Large firms are motivated to comply with the regulations because of the deterrent fear of negative media coverage, social motivations, ability to comply and maintaining a competitive market advantage. In contrast, SMEs are motivated to comply due to the deterrent fear of legal prosecution and a sense of duty.
Related Concept Videos
Drug Regulation
Good Manufacturing Practices
Drug Control Governance: Regulatory Bodies and Their Impact
Standards of Care II
Clinically Relevant Drug Product Specifications: Methods of Establishment
Hazard Analysis and Critical Control Points (HACCP)
